drugset / Trial / NCT06666491

An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older

NCT06666491

Phase 3 Recruiting 300 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to collect efficacy and safety data to support the registration of tafenoquine in India.

Timeline

Start
2024-11-13
Primary completion
2026-05-25
Completion
2026-05-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Primaquine Small molecule Oral
Subject Tafenoquine Small molecule Oral
Background Chloroquine Small molecule Oral